로딩 중…
지수 로딩 중…
Coherus Oncology, Inc.
CHRS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.48+6.47%
2026-06-18
Price Chart
Coherus Oncology, Inc.+92.81%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $228M |
| Revenue | $47M |
| Net Income | $187M |
| Total Assets | $266M |
| Net Assets | $79M |
| Value | |
| P/E | 1.22x |
| P/B | 2.90x |
| P/S | 4.87x |
| FCF Yield | -74.72% |
| Profitability | |
| ROA | 70.46% |
| Op. Margin | -362.07% |
| Revenue Growth | 61.99% |
| Earnings Growth | -697.37% |
| Financial Health | |
| Debt Ratio | 238.35% |
| Total Debt | $54M |
| FCF | $-171M |
| Cash | $115M |
| Current Ratio | 1.56x |
| Performance | |
| 1Y Return | 92.81% |
| 1M Return | 0.00% |
| From 52W High | -43.51% |
| 1Y MDD | -45.82% |
| Trading | |
| Volume | 1,256,872 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $-1.41 |
| BPS | $0.51 |